Caitong International Asset Management Co., LTD Vaxcyte, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 295 shares of PCVX stock, worth $10,112. This represents 0.02% of its overall portfolio holdings.
Number of Shares
295
Previous 295
-0.0%
Holding current value
$10,112
Previous $24.1 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding PCVX
# of Institutions
355Shares Held
127MCall Options Held
539KPut Options Held
253K-
Vanguard Group Inc Valley Forge, PA12MShares$410 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X010.6MShares$363 Million0.46% of portfolio
-
Black Rock Inc. New York, NY9.94MShares$341 Million0.02% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.69MShares$298 Million11.52% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.21MShares$213 Million0.11% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $2.03B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...